NCT00292110View on ClinicalTrials.gov

Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2004

Primary Completion Date

August 9, 2013

Study Completion Date

August 9, 2013

Conditions
Opiate-Related DisordersCocaine-Related Disorders
Interventions
DRUG

Methadone

100 mg/day orally

BEHAVIORAL

Contingency Management

Incentives given for cocaine abstinence

DRUG

Methadone dose

flexible methadone dosing to 190 mg/day daily orally

BEHAVIORAL

Contingency Management/Noncontingent Incentives

Incentives given independent of drug use

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00292110 - Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management | Biotech Hunter | Biotech Hunter